Skip to content

Health Catalyst HCAT Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

International Business Machines logo
International Business MachinesIBM
Spok Holdings logo
Spok HoldingsSPOK
CareCloud, Inc. logo
CareCloud, Inc.CCLD
Claritev Corporation logo
Claritev CorporationCTEV
IQVIA logo
IQVIAIQV
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM

Other financials

Income statement

See full
Revenue$70.8M-10.9%
Gross profit$35.5M-2.1%
Operating income-$106.5M-428%
Net income-$111.0M-368%
EPS (diluted)-$1.53-337%

Balance sheet

See full
Cash & equivalents$59.9M-82.5%
Total debt$170.6M-57.6%
Total equity$138.1M-63.3%
Total assets$412.2M-53.8%

Cash flow

See full
Operating cash flow$18.5M+6,511%
CapEx$338.0K-49.6%
Free cash flow$18.2M+4,760%

Valuation

See full
Market cap$147.05M-43.6%
Enterprise value$257.76M-32.7%
P/S0.5×-0.3×

Profitability

See full
Gross margin49.9%+4.7pp
Operating margin-81.7%-127pp
Net margin-87.7%-138pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-103%-135pp
Debt / equity1.2×+0.2×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by Health Catalyst in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: Health Catalyst’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Health Catalyst's common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Health Catalyst's common stock, shares, outstanding?
Health Catalyst (HCAT) reported common stock, shares, outstanding of $73.75M in Q1 2026.
How has Health Catalyst's common stock, shares, outstanding changed year-over-year?
Health Catalyst's common stock, shares, outstanding increased by 6.1% year-over-year, from $69.48M to $73.75M.
What is the long-term trend for Health Catalyst's common stock, shares, outstanding?
Over 5 years (2020 to 2025), Health Catalyst's common stock, shares, outstanding has grown at a 10.7% compound annual growth rate (CAGR), from $43.38M to $72.03M.